EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma

Mingen Lin, Jing He, Xinchao Zhang, Xue Sun, Wenjing Dong, Ruonan Zhang, Yanping Xu, Lei Lv

Journal of Clinical Investigation · 01.05.2023 · 133 (9)

DOI: 10.1172/jci164528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.05.2023. Verfasst von Mingen Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAnimalsMiceB7-H1 AntigenFibrinogenImmunotherapySirtuin 2

Stichwörter der Autor:innen

Cancer immunotherapyCell BiologyImmunologyImmunotherapyLiver cancer

Substanzen

B7-H1 AntigenFibrinogenSirtuin 2Fgl1 protein, mouse

Autor:innen und Institutionen

  • Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.

Zitieren

APA

Lin, M., He, J., Zhang, X., Sun, X., Dong, W., Zhang, R., Xu, Y., & Lv, L. (2023). Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma. Journal of Clinical Investigation, 133(9). https://doi.org/10.1172/jci164528

Vancouver

Lin M, He J, Zhang X, Sun X, Dong W, Zhang R, et al. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma. Journal of Clinical Investigation. 2023;133(9). doi:10.1172/jci164528

BibTeX
@article{Lin2023,
  author = {Lin, Mingen and He, Jing and Zhang, Xinchao and Sun, Xue and Dong, Wenjing and Zhang, Ruonan and Xu, Yanping and Lv, Lei},
  title = {Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {9},
  doi = {10.1172/jci164528}
}
Kostenlos starten →